ArticleFrontiers in immunology2022

Pembrolizumab Plus Chemotherapy Versus Chemotherapy Monotherapy as a First-Line Treatment in Elderly Patients (≥75 Years Old) With Non-Small-Cell Lung Cancer.

Zhengyu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.